Literature DB >> 19634969

Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.

Jay C Fournier1, Robert J DeRubeis, Richard C Shelton, Steven D Hollon, Jay D Amsterdam, Robert Gallop.   

Abstract

A recent randomized controlled trial found nearly equivalent response rates for antidepressant medications and cognitive therapy in a sample of moderate to severely depressed outpatients. In this article, the authors seek to identify the variables that were associated with response across both treatments as well as variables that predicted superior response in one treatment over the other. The sample consisted of 180 depressed outpatients: 60 of whom were randomly assigned to cognitive therapy; 120 were assigned to antidepressant medications. Treatment was provided for 16 weeks. Chronic depression, older age, and lower intelligence each predicted relatively poor response across both treatments. Three prescriptive variables-marriage, unemployment, and having experienced a greater number of recent life events-were identified, and each predicted superior response to cognitive therapy relative to antidepressant medications. Thus, 6 markers of treatment outcome were identified, each of which might be expected to carry considerable clinical utility. The 3 prognostic variables identify subgroups that might benefit from alternative treatment strategies; the 3 prescriptive variables identify groups who appear to respond particularly well to cognitive therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634969      PMCID: PMC2810269          DOI: 10.1037/a0015401

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  53 in total

1.  Natural classes of treatment response.

Authors:  A R Morral; M Y Iguchi; M A Belding; R J Lamb
Journal:  J Consult Clin Psychol       Date:  1997-08

2.  When and how perfectionism impedes the brief treatment of depression: further analyses of the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

Authors:  S J Blatt; D C Zuroff; C M Bondi; C A Sanislow; P A Pilkonis
Journal:  J Consult Clin Psychol       Date:  1998-04

3.  Small sample inference for fixed effects from restricted maximum likelihood.

Authors:  M G Kenward; J H Roger
Journal:  Biometrics       Date:  1997-09       Impact factor: 2.571

4.  The efficacy of imipramine and psychotherapy in early-onset chronic depression: a reanalysis of the National Institute of Mental health Treatment of Depression Collaborative Research Program.

Authors:  V Agosti; K Ocepek-Welikson
Journal:  J Affect Disord       Date:  1997-05       Impact factor: 4.839

5.  Effect of age on the outcome of hospital treated depression.

Authors:  T A Tuma
Journal:  Br J Psychiatry       Date:  1996-01       Impact factor: 9.319

6.  Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression.

Authors:  I M Blackburn; R G Moore
Journal:  Br J Psychiatry       Date:  1997-10       Impact factor: 9.319

7.  Major depressive subtypes and treatment response.

Authors:  M Fava; L A Uebelacker; J E Alpert; A A Nierenberg; J A Pava; J F Rosenbaum
Journal:  Biol Psychiatry       Date:  1997-10-01       Impact factor: 13.382

8.  The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program.

Authors:  J P Barber; L R Muenz
Journal:  J Consult Clin Psychol       Date:  1996-10

9.  Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

Authors:  I Elkin; R D Gibbons; M T Shea; S M Sotsky; J T Watkins; P A Pilkonis; D Hedeker
Journal:  J Consult Clin Psychol       Date:  1995-10

10.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.

Authors:  M E Thase; J B Greenhouse; E Frank; C F Reynolds; P A Pilkonis; K Hurley; V Grochocinski; D J Kupfer
Journal:  Arch Gen Psychiatry       Date:  1997-11
View more
  93 in total

1.  Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Jessica A Johnson; Ewgeni Jakubovski; Margot O Reed; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-08-03       Impact factor: 2.576

2.  Pre-treatment predictors of dropout from prolonged exposure therapy in patients with chronic posttraumatic stress disorder and comorbid substance use disorders.

Authors:  Emily L Belleau; Eu Gene Chin; Sonya G Wanklyn; Laura Zambrano-Vazquez; Julie A Schumacher; Scott F Coffey
Journal:  Behav Res Ther       Date:  2017-01-25

Review 3.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

4.  Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?

Authors:  Michael G Wheaton; David Rosenfield; Edna B Foa; H Blair Simpson
Journal:  J Consult Clin Psychol       Date:  2015-05-25

5.  Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study.

Authors:  Jerome H Taylor; Eli R Lebowitz; Ewgeni Jakubovski; Catherine G Coughlin; Wendy K Silverman; Michael H Bloch
Journal:  J Clin Child Adolesc Psychol       Date:  2017-09-28

6.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

7.  Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.

Authors:  Boadie W Dunlop; Devon LoParo; Becky Kinkead; Tanja Mletzko-Crowe; Steven P Cole; Charles B Nemeroff; Helen S Mayberg; W Edward Craighead
Journal:  Am J Psychiatry       Date:  2019-02-15       Impact factor: 18.112

8.  Treating co-occurring depression and anxiety: modeling the dynamics of psychopathology and psychotherapy using the time-varying effect model.

Authors:  Aidan G C Wright; Michael N Hallquist; Holly A Swartz; Ellen Frank; Jill M Cyranowski
Journal:  J Consult Clin Psychol       Date:  2013-09-16

9.  Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response?

Authors:  Robin B Jarrett; Abu Minhajuddin; Julie L Kangas; Edward S Friedman; Judith A Callan; Michael E Thase
Journal:  Behav Res Ther       Date:  2013-05

10.  Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.

Authors:  Laurie J Zandberg; David Rosenfield; Elizabeth Alpert; Carmen P McLean; Edna B Foa
Journal:  Behav Res Ther       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.